Hence, discovering the functional mechanism by which Aβ regulates cell cycle re-entry by exploiting the mTOR signaling pathway serves as a novel target for the treatment and/or prevention of AD pathogenesis. This evidence concerns the gene MTOR and Alzheimer disease.